From Web3 to Quantum: Small-Cap Innovators OFAL, SPRC, XXII Lead Market Movers as XHLD Builds Visibility

September 25, 2025

DENVER, Colo., Sep 25, 2025 (247marketnews.com)- U.S. markets opened on stable footing this Thursday morning, but the small-cap segment is seeing outsized moves fueled by innovation, insurance windfalls, and strategic visibility plays.

OFA Group (NASDAQ:OFAL) leapt after unveiling a strategic AI + Web3 initiative in real estate finance. Partnering with Blockchain App Factory, OFA is building a tokenized real estate equity and mortgage RWA platform, targeting a Minimum Viable Product within four months. The platform will integrate AI for valuation and compliance and Web3 for fractional trading, with a $100 million crypto treasury to follow.

CEO Larry Wong said the initiative marks a shift toward “innovation, transparency, and sustainable growth” in real-world asset tokenization.

SciSparc (NASDAQ:SPRC) announced a pioneering quantum computing initiative to enable 3D protein modeling for AI-driven drug discovery. The company plans to simulate protein folding and ligand interactions at quantum-scale precision, addressing neurological and rare disease targets. A new wholly owned Israeli subsidiary will lead the effort, with support from domain experts in quantum mechanics and structural biology.

22nd Century Group (NASDAQ:XXII) is on the move after securing a $9.5 million insurance settlement for business interruption, bolstering its balance sheet with non-dilutive capital. Now debt-free, the company is pivoting from “survival capital to growth capital,” according to CEO Larry Firestone. With plans to scale low-nicotine VLN product distribution, 22nd Century is targeting profitability by 2026.

TEN Holdings (NASDAQ:XHLD) is building momentum behind the scenes, announcing participation in three key investor events, MicroCap Rodeo (NY, Sept 25), LD Micro Main Event (San Diego, Oct 19–21), and Spartan Capital Conference (NYC, Nov 3). The company describes the events as “critical opportunities” to engage with investors and signal future milestones, possibly hinting at upcoming acquisitions or product rollouts.

Plus Therapeutics (NASDAQ:PSTV) remains on trading radars after recent updates to its targeted radionuclide therapy pipeline. Investors are watching for trial progress on Rhenium-186 NanoLiposome candidates in glioblastoma and leptomeningeal metastases.

AtlasClear Holdings (NASDAQ:ATCH) continues positioning itself in the AI-powered clearing and trading infrastructure space. With broader fintech sentiment turning cautiously optimistic, the company may benefit from renewed interest in real-time settlement tech.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by paid by Microcap Advisory for providing ongoing XHLD market outreach and other services. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/ or go to https://247marketnews.com/ten-holdings-event-solutions/ for additional 247marketnews.com XHLD disclosure. 247 has been paid by Microcap Advisory for providing ongoing XHLD market outreach and other services. This press release may include technical analysis for instructional purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (XHLD, OFAL, XXII, SPRC, PSTV, ATCH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.